France· FR:65006905
ODOMZO 200 mg, gélule
A medicinal product containing phosphate de sonidégib, registered in France by SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PHOSPHATE DE SONIDÉGIB
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930030721plaquette(s) polychlortrifluoroéthylène PVC aluminium de 30 gélule(s)EUR 4.26
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phosphate de sonidégib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandOdomzo 200 mg, HartkapselnSun Pharma Switzerland Ltd
- CzechiaODOMZOSun Pharmaceutical Industries Europe B.V., Hoofddorp
- SpainODOMZO 200 MG CAPSULAS DURASSun Pharmaceutical Industries (Europe) B.V.
- FinlandOdomzoSun Pharmaceutical Industries Europe B.V.
- IrelandOdomzo 200 mg hard capsulesSun Pharmaceutical Industries Europe B.V.
- IcelandOdomzoSun Pharmaceutical Industries Europe B.V.*
- NorwayOdomzoSun Pharmaceutical - Nederland
- PolandOdomzoSun Pharmaceutical Industries Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Odomzo
- Norway · Odomzo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea92d131-13f2-45e3-a00c-2437a5c33bdf GET /v1/drugs/ea92d131-13f2-45e3-a00c-2437a5c33bdf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65006905",
"date_amm": "2015-08-14",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1030",
"substance": "PHOSPHATE DE SONIDÉGIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about phosphate de sonidégib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.